Search research articles
Contact Us
Filters
Showing results (31-40 of 157) with videos related to
Page
of 16
Sort By:
Clinical Pharmacology and Therapeutics
|
January 24, 2025
Effect of Target-Mediated Disposition on Iptacopan Clinical Pharmacokinetics in Participants with Normal or Impaired Hepatic Function
Elise Burmeister Getz, Richard R Stein, Martin Fink, et al.
Journal of Clinical Gastroenterology
|
March 14, 2020
Accuracy of Noninvasive Fibrosis Scores to Detect Advanced Fibrosis in Patients With Type-2 Diabetes With Biopsy-proven Nonalcoholic Fatty Liver Disease
Amandeep Singh, Falgun Gosai, Mohamed T Siddiqui, et al.
Antiviral Research
|
January 25, 2011
Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy
Eric Lawitz, Eliot Godofsky, Regine Rouzier, et al.
World Journal of Hepatology
|
November 22, 2019
Characterization of patients with both alcoholic and nonalcoholic fatty liver disease in a large United States cohort
George Khoudari, Amandeep Singh, Mazen Noureddin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 30, 2018
Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertib
Zobair M Younossi, Maria Stepanova, Eric Lawitz, et al.
Plos One
|
August 31, 2018
Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis
Naim Alkhouri, Casey Johnson, Leon Adams, et al.
Journal of Hepatology
|
June 24, 2023
A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease
Manuel Romero-Gómez, Eric Lawitz, R Ravi Shankar, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 10, 2013
Effects of sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis C
Zobair M Younossi, Maria Stepanova, Linda Henry, et al.
Plos One
|
October 5, 2018
Correction: Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis
Naim Alkhouri, Casey Johnson, Leon Adams, et al.
Gastro Hep Advances
|
June 15, 2026
Assessment of Esophageal and Gastric Varices in Patients With Cirrhosis for Clinical Trials: A Centralized Blinded Evaluation System
Naim Alkhouri, Raj Vuppalanchi, Mazen Noureddin, et al.
Page
of 16
Search research articles
Search
Showing results (31-40 of 157) with videos related to
Sort By:
Page
of 16
Clinical Pharmacology and Therapeutics
|
January 24, 2025
Effect of Target-Mediated Disposition on Iptacopan Clinical Pharmacokinetics in Participants with Normal or Impaired Hepatic Function
Elise Burmeister Getz, Richard R Stein, Martin Fink, et al.
Journal of Clinical Gastroenterology
|
March 14, 2020
Accuracy of Noninvasive Fibrosis Scores to Detect Advanced Fibrosis in Patients With Type-2 Diabetes With Biopsy-proven Nonalcoholic Fatty Liver Disease
Amandeep Singh, Falgun Gosai, Mohamed T Siddiqui, et al.
Antiviral Research
|
January 25, 2011
Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy
Eric Lawitz, Eliot Godofsky, Regine Rouzier, et al.
World Journal of Hepatology
|
November 22, 2019
Characterization of patients with both alcoholic and nonalcoholic fatty liver disease in a large United States cohort
George Khoudari, Amandeep Singh, Mazen Noureddin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 30, 2018
Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertib
Zobair M Younossi, Maria Stepanova, Eric Lawitz, et al.
Plos One
|
August 31, 2018
Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis
Naim Alkhouri, Casey Johnson, Leon Adams, et al.
Journal of Hepatology
|
June 24, 2023
A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease
Manuel Romero-Gómez, Eric Lawitz, R Ravi Shankar, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 10, 2013
Effects of sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis C
Zobair M Younossi, Maria Stepanova, Linda Henry, et al.
Plos One
|
October 5, 2018
Correction: Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis
Naim Alkhouri, Casey Johnson, Leon Adams, et al.
Gastro Hep Advances
|
June 15, 2026
Assessment of Esophageal and Gastric Varices in Patients With Cirrhosis for Clinical Trials: A Centralized Blinded Evaluation System
Naim Alkhouri, Raj Vuppalanchi, Mazen Noureddin, et al.
Page
of 16